M&A Deal Summary

Berkeley Lights Acquires IsoPlexis

On December 21, 2022, Berkeley Lights acquired life science company IsoPlexis for 58M USD

Acquisition Highlights
  • This is Berkeley Lights’ 1st transaction in the Life Science sector.
  • This is Berkeley Lights’ largest (disclosed) transaction.
  • This is Berkeley Lights’ 1st transaction in the United States.
  • This is Berkeley Lights’ 1st transaction in Connecticut.

M&A Deal Summary

Date 2022-12-21
Target IsoPlexis
Sector Life Science
Buyer(s) Berkeley Lights
Deal Type Add-on Acquisition
Deal Value 58M USD
Advisor(s) Evercore Group (Financial)
Cravath, Swaine & Moore (Legal)

Target

IsoPlexis

Branford, Connecticut, United States
IsoPlexis is a life sciences company developing a diagnostic platform that identifies a wide range of patient immune responses at the cellular level. Its platform can assess safety and efficacy of therapeutics and monitor disease progression, enabling improved therapeutic development and informing physician decisions. IsoPlexis was founded in 2013 and is based in Branford, Connecticut.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Berkeley Lights

Emeryville, California, United States

Category Company
Founded 2011
Sector Life Science
Employees293
Revenue 85M USD (2021)
DESCRIPTION

Berkeley Lights is a digital cell biology company that focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. It offers an integrated platform, which comprises of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. Berkeley Lights was incorporated in 2011 and is based in Emeryville, California.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Connecticut) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1